NAV · Direct-Growth
As of 1 Oct 2026 · AMFI
Returns
Beats category
1Y, 3Y all ahead
Cost
High
0.92% vs 0.83% peers
Volatility
Below average
16.1% vs 16.3% cat (3Y)
Consistency
Strong
positive in 3 of 3 years
Beats its Sectoral / Thematic category on 1Y & 3Y — and has been steadier than peers.
1Y return
+26.9%
+24.1 vs cat
3Y CAGR
+30.2%
+16.2 vs cat
5Y CAGR
—
AUM
₹2.4K Cr
fund size
Expense
0.92%
direct plan
Volatility 3Y
16.1%
▼ vs 16.3%
In plain English
HDFC Pharma and Healthcare Fund is a Sectoral / Thematic scheme from HDFC. The portfolio is ~99% in equities. 3-year CAGR: about 30.2%. Worst historical drawdown: -15% in Feb 2025, recovered in 4 months. Wrong fit if you need this money in less than 7 years.
Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.
NAV history
Showing Direct · Growth · INF179KC1HO1
NAV (Direct-Growth)
₹21.9790
Last 1Y
+26.61%
Drawdown stories
The crashes you should know about — and how long the fund took to recover.
Feb 2025
-14.9%Peak ₹17.42 on 2 Jan 2025 → trough ₹14.82 on 28 Feb 2025 (2 months down).
Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.
Honesty score
A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.
Honesty score
4 / 5
Solid scheme on the dimensions we check. No red flags.
Expense ratio
0.92% — typical for category.
AUM size
₹2.4K Cr.
Sector concentration
Top 3 sectors = 98.7% — heavy concentration risk.
Performance
Returns for various periods, with category average and peer rank.
Portfolio composition
Asset allocation
- Equity98.70%
- Cash1.30%
By market cap
- Large cap27.41%
- Mid cap34.24%
- Small cap33.75%
- Others4.60%
Concentration
Holdings
34
Avg market cap
₹53.3K Cr
Top 10 stocks
54.55%
Top 5 stocks
33.12%
Top 3 sectors
98.70%
Top holdings
Top 15 positions by weight, latest disclosure.
Fundamentals (vs category)
Portfolio-weighted ratios, compared with the category average.
Risk metrics
Standard deviation, Sharpe, Sortino, Beta — all vs category average.
Peers in Sectoral / Thematic
Other schemes in the same SEBI category, ranked by AUM.
Available plans & options
Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.
NEW
See your SIP through Indian market history
Pick a fund and a start year — get a 60-second cinematic replay of every crash, boom, and headline with your money in it. Real NAV data, no “assumed 12%” lies.
Try Wealth Time MachineAI · Free
Find what's really inside your funds
Upload your CAS PDF — get instant stock concentration, hidden fund overlap, sector risk, and 3 key insights, written by AI in plain English.
Run Portfolio X-Ray